Kim KW - Search Results

1

Anti-angiogenic activity of ursodeoxycholic acid and its derivatives.

Suh H, Jung EJ, Kim TH, Lee HY, Park YH, Kim KW. Suh H, et al. Among authors: kim th, kim kw. Cancer Lett. 1997 Feb 26;113(1-2):117-22. doi: 10.1016/s0304-3835(97)04604-1. Cancer Lett. 1997. PMID: 9065810

2

Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives.

Kim DK, Lee JR, Kim A, Lee S, Yoo MA, Kim KW, Kim ND, Suh H. Kim DK, et al. Among authors: kim a, kim nd, kim kw. Cancer Lett. 1999 Nov 15;146(2):147-53. doi: 10.1016/s0304-3835(99)00251-7. Cancer Lett. 1999. PMID: 10656619

3

Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells.

Im EO, Choi YH, Paik KJ, Suh H, Jin Y, Kim KW, Yoo YH, Kim ND. Im EO, et al. Among authors: kim nd, kim kw. Cancer Lett. 2001 Feb 10;163(1):83-93. doi: 10.1016/s0304-3835(00)00671-6. Cancer Lett. 2001. PMID: 11163111

4

Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA).

Park YH, Kim JA, Baek JH, Jung EJ, Kim TH, Suh H, Park MH, Kim KW. Park YH, et al. Among authors: kim th, kim ja, kim kw. Arch Pharm Res. 1997 Feb;20(1):29-33. doi: 10.1007/BF02974038. Arch Pharm Res. 1997. PMID: 18975208

5

Anti-angiogenic activity of triterpene acids.

Sohn KH, Lee HY, Chung HY, Young HS, Yi SY, Kim KW. Sohn KH, et al. Among authors: kim kw. Cancer Lett. 1995 Aug 1;94(2):213-8. doi: 10.1016/0304-3835(95)03856-r. Cancer Lett. 1995. PMID: 7543366

6

Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases.

Choi YH, Im EO, Suh H, Jin Y, Lee WH, Yoo YH, Kim KW, Kim ND. Choi YH, et al. Among authors: kim nd, kim kw. Int J Oncol. 2001 May;18(5):979-84. doi: 10.3892/ijo.18.5.979. Int J Oncol. 2001. PMID: 11295044

7

Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.

Cha HJ, Bae SK, Lee HY, Lee OH, Sato H, Seiki M, Park BC, Kim KW. Cha HJ, et al. Among authors: kim kw. Cancer Res. 1996 May 15;56(10):2281-4. Cancer Res. 1996. PMID: 8625299

8

Reduced expression of PLC-gamma during the differentiation of mouse F9 teratocarcinoma cells.

Lee YH, Lee HY, Ryu SH, Suh PG, Kim KW. Lee YH, et al. Among authors: kim kw. Cancer Lett. 1993 Feb;68(2-3):237-42. doi: 10.1016/0304-3835(93)90152-y. Cancer Lett. 1993. PMID: 8383002

9

In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells.

Lee YN, Lee HY, Chung HY, Kim SI, Lee SK, Park BC, Kim KW. Lee YN, et al. Among authors: kim si, kim kw. Eur J Cancer. 1996 Jul;32A(8):1420-8. doi: 10.1016/0959-8049(96)00102-5. Eur J Cancer. 1996. PMID: 8869109

10

Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity.

Bae MH, Lee MJ, Bae SK, Lee OH, Lee YM, Park BC, Kim KW. Bae MH, et al. Among authors: kim kw. Cancer Lett. 1998 Jun 5;128(1):41-6. doi: 10.1016/s0304-3835(98)00044-5. Cancer Lett. 1998. PMID: 9652791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,671 results

Search Page

Filters